RECORD // Company

Biolargo, Inc.

Formerly: NUWAY MEDICAL INC; NUWAY ENERGY INC; LATIN AMERICAN CASINOS INC

Built 2026-11-22T03:10:13Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • BioLargo, Inc. · legal entity in this company's GLEIF ownership tree (LEI 5493007RC0EO4XEQU443)
SEC EDGAR (1)
Matched by name only, not merged (1)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • BIOLARGO, INC. · USAspending · same registered legal name as 'BIOLARGO, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare

5 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001437749-26-037232

ItemValuePeriodFormFiledAccessionReport
Revenue$1,090,0003 months ended 2026-09-3010-Q2026-11-160001437749-26-0372322026-11-22 03:10 UTCReport an error
Net income (loss)$-3,824,0003 months ended 2026-09-3010-Q2026-11-160001437749-26-0372322026-11-22 03:10 UTCReport an error
Interest expense$317,0003 months ended 2026-09-3010-Q2026-11-160001437749-26-0372322026-11-22 03:10 UTCReport an error
Cash and cash equivalents$1,533,000at 2026-09-3010-Q2026-11-160001437749-26-0372322026-11-22 03:10 UTCReport an error
Contract liabilities, current$615,000at 2026-09-3010-Q2026-11-160001437749-26-0372322026-11-22 03:10 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0000880242
Ticker
BLGO
EIN
650159115
Record ID
sx:sec:0000880242

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

22 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 03:10 UTCReport an error
SIC industry2800 Chemicals & Allied Products2026-11-16SEC EDGAR company profile2026-11-22 03:10 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 03:10 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 03:10 UTCReport an error
Business address14921 CHESTNUT ST., WESTMINSTER, CA, 926832026-11-16SEC EDGAR company profile2026-11-22 03:10 UTCReport an error
ExchangesOTC2026-11-16SEC EDGAR company profile2026-11-22 03:10 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$7,765,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerIncludingAssessedTax2026-11-22 03:10 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-15,189,0002025-12-3110-K, XBRL ProfitLoss2026-11-22 03:10 UTCReport an error
Total assets (at 2025-12-31)$8,311,0002025-12-3110-K, XBRL Assets2026-11-22 03:10 UTCReport an error
Stockholders' equity (at 2025-12-31)$4,042,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 03:10 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$3,883,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:10 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-8,297,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:10 UTCReport an error
Long-term debt (at 2025-12-31)$2,079,0002025-12-3110-K, XBRL LongTermDebt2026-11-22 03:10 UTCReport an error
Operating lease liabilities (at 2025-12-31)$1,074,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 03:10 UTCReport an error
Form D total offering amount (D filed 2024-01-23)$815,0002024-01-23D2026-11-22 03:10 UTCReport an error
Form D total amount sold (D filed 2024-01-23)$815,0002024-01-23D2026-11-22 03:10 UTCReport an error
Form D industry groupOther2024-01-23D2026-11-22 03:10 UTCReport an error
Form D revenue range$5,000,001 - $25,000,0002024-01-23D2026-11-22 03:10 UTCReport an error
Form D date of first sale2023-11-172024-01-23D2026-11-22 03:10 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-02)On November 2, 2026, BioLargo, Inc. published the press released attached as Exhibit 99.1, which is incorporated by this reference, and posted a video on its YouTube channel, a transcript of which is attached as Exhibit 99.2. The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 and Exhibit 99.2 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the exhibits to this Current Report shall not be incorporated by…2026-11-02SEC EDGAR 8-K 0001437749-26-034271 (text as filed, excerpt)2026-11-22 03:10 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-09-14)BioLargo, Inc. presented the slides attached as Exhibit 99.1, which are incorporated herein by reference, on September 10, 2026, at 1:00 PM Pacific Time, at a webcast investor conference. The transcript of the webcast is attached as Exhibit 99.2. The information in this Item 7.01 of this Current Report on Form 8-K/A and Exhibit 99.1 and Exhibit 99.2 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the exhibits to this Current Report shall not…2026-09-14SEC EDGAR 8-K 0001437749-26-030198 (text as filed, excerpt)2026-11-22 03:10 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-09-11)BioLargo, Inc. presented the slides attached as Exhibit 99.1, which are incorporated herein by reference, on September 10, 2026, at 1:00 PM Pacific Time, at a webcast investor conference. The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the exhibits to this Current Report shall not be incorporated by reference into any filing with the SEC made by the Company…2026-09-11SEC EDGAR 8-K 0001437749-26-030124 (text as filed, excerpt)2026-11-22 03:10 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.